S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
8-K: Current report
8-K: Current report
8-K: X4 Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Corporate Updates
8-K: Current report
8-K: Current report
8-K: Current report
8-K: Current report
8-K: Current report
8-K: X4 Pharmaceuticals Reports First-Quarter 2024 Financial Results and Provides Corporate Updates
DEFA14A: Others
DEF 14A: Definitive information statements
8-K: Current report
8-K: Current report
X4 PHARMACEUTICALS INC C/WTS 16/04/24(TO PUR COM) CL A | 8-K: Current report
X4 PHARMACEUTICALS INC C/WTS 16/04/24(TO PUR COM) CL A | 8-K: Current report
No Data
No Data